nach oben

Journal of Clinical Immunology

Erschienen in:

01.02.2013 | Original Research

Glucocorticoid Receptor-Beta Up-Regulation and Steroid Resistance Induction by IL-17 and IL-23 Cytokine Stimulation in Peripheral Mononuclear Cells

verfasst von: Alejandro Vazquez-Tello, Rabih Halwani, Qutayba Hamid, Saleh Al-Muhsen

Erschienen in: Journal of Clinical Immunology | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Most asthmatic patients have well controlled symptoms with regular treatment, but some require much higher doses of inhaled and oral corticosteroids, or in rare cases fail to respond; these patients may present Th-17 cell infiltration and associated cytokines (IL-17A and -F) in the airways, sputum and peripheral blood. Because glucocorticoid receptor-beta (GR-beta) is associated with corticosteroid resistance, we investigated whether Th-17 associated cytokines induce steroid insensitivity in PBMCs via GR-beta up-regulation.

Methods

GR-alpha, GR-beta, GILZ and IL-6 expression were analyzed in PBMCs stimulated with IL-2/IL-4, IL-17A/IL-17F and IL-23 cytokines by quantitative RT-PCR. Dexamethasone-inhibition of PHA-induced proliferation and Dexamethasone-induced apoptosis were determined by either ³H-thymidine or CFSE-labelled cells and by Annexin-V staining and flow cytometry.

Results

IL-17 and IL-23 cytokines significantly increased GR-beta expression. IL-2/IL-4 significantly decreased GR-alpha expression without affecting GR-beta. IL17, IL-23 and IL2 + 4 stimulations significantly hampered Dexamethasone-inhibition of proliferation (Dex EC₅₀ for: IL-17A + F = 251 nM; IL-23 = 435 nM; IL2 + 4 = 950 nM; Medium = 90 nM). IL2 + 4 and IL17A + F but not IL-23, significantly hampered Dexamethasone-induced apoptosis (1400 and 320 nM Dex, respectively). Dexamethasone’s trans-activation of GILZ and trans-repression of NF-kB-driven IL-6 expression were both inhibited by IL2 + 4; IL17 + IL23 antagonized Dex trans-repression in PBMC from asthmatics.

Conclusions

GR-beta up-regulation by IL-17/IL-23 cytokines is associated with induced steroid insensitivity in PBMCs, observed as diminished Dexamethasone’s effects on cell proliferation, apoptosis and gene regulation. Steroid resistance induced by IL-2/IL-4 was associated with decreased GR-alpha expression. This study supports the possibility that Th-17 lymphocytes and associated cytokines play a role in the mechanism of steroid hypo-responsiveness in severe asthmatics.

Nur mit Berechtigung zugänglich

Riordan JF, Dash CH, Sillett RW, McNicol MW. A comparison of betamethasone valerate, beclomethasone dipropionate and placebo by inhalation for the treatment of chronic asthma. Postgrad Med J. 1974;50 suppl 4:61–4.PubMed

Szefler SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM, et al. Significant variability in response to inhaled corticosteroids for persistent asthma. Allergy Clin Immunol. 2002;109:410–8.CrossRef

Masoli M, Holt S, Weatherall M, Beasley R. The dose–response relationship of inhaled corticosteroids in asthma. Curr Allergy Asthma Rep. 2004;4:144–8.PubMedCrossRef

Senn S. Individual response to treatment: is it a valid assumption? BMJ. 2004;329:966–8.PubMedCrossRef

Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol. 2005;115:233–42.PubMedCrossRef

Sher ER, Leung DY, Surs W, Kam JC, Zieg G, Kamada AK, Szefler SJ. Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest. 1994;93:33–9.PubMedCrossRef

Gagliardo R, Chanez P, Vignola AM, Bousquet J, Vachier I, Godard P, et al. Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. Am J Respir Crit Care Med. 2000;162:7–13.PubMed

Martin RJ, Szefler SJ, King TS, Kraft M, Boushey HA, Chinchilli VM, Craig TJ, et al. The predicting response to inhaled corticosteroid efficacy (PRICE) trial. J Allergy Clin Immunol. 2007;119:73–80.PubMedCrossRef

Corrigan CJ, Brown PH, Barnes NC, Szefler SJ, Tsai JJ, Frew AJ, Kay AB. Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis. 1991;144:1016–25.PubMedCrossRef

10.

Leung DY, Hamid Q, Vottero A, Szefler SJ, Surs W, Minshall E, et al. Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor β. J Exp Med. 1997;186:1567–74.PubMedCrossRef

11.

Kam JC, Szefler SJ, Surs W, Sher ER, Leung DY. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol. 1993;151:3460–6.PubMed

12.

Goleva E, Martin RJ, Leung DYM. Combination of IL-2 and IL-4 inhibits glucocorticoid receptor alpha (GCR-alpha) nuclear translocation in peripheral blood mononuclear cells (PBMC) and this effect is reversed by gamma interferon. J Allergy Clin Immunol. 2004;113:S93.CrossRef

13.

Adcock IM, Barnes PJ. Molecular mechanisms of corticosteroid resistance. Chest. 2008;134:394–401.PubMedCrossRef

14.

Oakley RH, Sar M, Cidlowski JA. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J Biol Chem. 1996;271:9550–9.PubMedCrossRef

15.

Leung DYM, Szefler SJ. New insights into steroid resistant asthma. Pediatr Allergy Immunol. 1998;9:3–12.PubMedCrossRef

16.

Kim SH, Kim DH, Lavender P, Seo JH, Kim YS, Park JS, et al. Repression of TNF-alpha-induced IL-8 expression by the glucocorticoid receptor-beta involves inhibition of histone H4 acetylation. Exp Mol Med. 2009;41:297–306.PubMedCrossRef

17.

Tliba O, Cidlowski JA, Amrani Y. CD38 expression is insensitive to steroid action in cells treated with tumor necrosis factor-alpha and interferon-gamma by a mechanism involving the up-regulation of the glucocorticoid receptor beta isoform. Mol Pharmacol. 2006;69:588–96.PubMedCrossRef

18.

Hamid QA, Wenzel SE, Hauk PJ, Tsicopoulos A, Wallaert B, Lafitte JJ, et al. Increased glucocorticoid receptor beta in airway cells of glucocorticoid insensitive asthma. Am J Respir Crit Care Med. 1999;159:1600–4.PubMed

19.

Sousa AR, Lane SJ, Cidlowski JA, Staynov DZ, Lee TH. Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform. J Allergy Clin Immunol. 2000;105:943–50.PubMedCrossRef

20.

Vazquez-Tello A, Semlali A, Chakir J, Martin JG, Leung DY, Eidelman DH, Hamid Q. Induction of glucocorticoid receptor-beta expression in epithelial cells of asthmatic airways by T-helper type 17 cytokines. Clin Exp Allergy. 2010;40:1312–22.PubMedCrossRef

21.

Piotrowski P, Burzynski M, Lianeri M, Mostowska M, Wudarski M, Chwalinska-Sadowska H, et al. Glucocorticoid receptor beta splice variant expression in patients with high and low activity of systemic lupus erythematosus. Folia Histochem Cytobiol. 2007;45:339–42.PubMed

22.

Towers R, Naftali T, Gabay G, Carlebach M, Klein A, Novis B. High levels of glucocorticoid receptors in patients with active Crohn’s disease may predict steroid resistance. Clin Exp Immunol. 2005;141:357–62.PubMedCrossRef

23.

McKinley L, Alcorn JF, Peterson A, Dupont RB, Kapadia S, Logar A, et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol. 2008;181:4089–97.PubMed

24.

Nakajima H, Hirose K. Role of IL-23 and Th17 cells in airway inflammation in asthma. Immune Netw. 2010;10:1–4.PubMedCrossRef

25.

Linden A, Adachi M. Neutrophilic airway inflammation and IL-17. Allergy. 2002;57:769–75.PubMedCrossRef

26.

Barczyk A, Pierzcha W, Sozanska E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med. 2003;97:726–33.PubMedCrossRef

27.

Laan M, Lötvall J, Chung KF, Lindén A. IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases. Br J Pharmacol. 2001;133:200–6.PubMedCrossRef

28.

Al-Ramli W, Préfontaine D, Chouiali F, Martin JG, Olivenstein R, Lemière C, et al. TH17-associated cytokines (IL-17A and IL-17F) in severe asthma. J Allergy Clin Immunol. 2009;123:1185–7.PubMedCrossRef

29.

Parish CR, Warren HS. Unit 4.9: use of the intracellular fluorescent dye CFSE to monitor lymphocyte migration and proliferation. In: Current protocols in immunology. John Wiley & Sons, Inc.; 2001.

30.

Barnes PJ. Corticosteroid resistance in airway disease. Proc Am Thorac Soc. 2004;1:264–8.PubMedCrossRef

31.

Yudt MR, Jewell CM, Bienstock RJ, Cidlowski JA. Molecular origins for the dominant negative function of human glucocorticoid receptor beta. Mol Cell Biol. 2003;23:4319–30.PubMedCrossRef

32.

Li LB, Leung DYM, Martin RJ, Goleva E. Inhibition of histone deacetylase 2 expression by elevated glucocorticoid receptor b in steroid-resistant asthma. Am J Respir Crit Care Med. 2010;182:877–83.PubMedCrossRef

33.

Wright JF, Bennett F, Li B, Brooks J, Luxenberg DP, Whitters MJ, et al. The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex. J Immunol. 2008;181:2799–805.PubMed

34.

Chang SH, Dong C. A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses. Cell Res. 2007;17:435–40.PubMed

35.

Gagliardo R, Vignola AM, Mathieu M. Is there a role for glucocorticoid receptor beta in asthma? Respir Res. 2001;2:1–4.PubMedCrossRef

36.

Pujols L, Mullol J, Roca-Ferrer J, Torrego A, Xaubet A, Cidlowski JA, et al. Expression of glucocorticoid receptor a- and b-isoforms in human cells and tissues. Am J Physiol Cell Physiol. 2002;283:C1324–31.PubMed

37.

de Castro M, Elliot S, Kino T, Bamberger C, Karl M, Webster E, Chrousos G. The non-ligand binding β-isoform of the human glucocorticoid receptor (hGRβ): tissue levels, mechanism of action, and potential physiologic role. Mol Med. 1996;2:597–607.PubMed

38.

Shahidi H, Vottero A, Stratakis CA, Taymans SE, Karl M, Longui CA, Chrousos GP, et al. Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia. Biochem Biophys Res Commun. 1999;254:559–65.PubMedCrossRef

39.

Kelly A, Bowen H, Jee YK, Mahfiche N, Soh C, Lee T, et al. The glucocorticoid receptor beta isoform can mediate transcriptional repression by recruiting histone deacetylases. Allergy Clin Immunol. 2008;121:203–8.CrossRef

40.

Kino T, Su YA, Chrousos GP. Human glucocorticoid receptor isoform beta: recent understanding of its potential implications in physiology and pathophysiology. Cell Mol Life Sci. 2009;66:3435–48.PubMedCrossRef

41.

Torrego A, Pujols L, Roca-Ferrer J, Mullol J, Xaubet A, Picado C. Glucocorticoid receptor isoforms alpha and beta in in vitro cytokine-induced glucocorticoid insensitivity. Am J Respir Crit Care Med. 2004;170:420–5.PubMedCrossRef

42.

Pariante CM, Pearce BD, Pisell TL, Sanchez CI, Po C, Su C, Miller AH. The proinflammatory cytokine interleukin-1α, reduces glucocorticoid receptor translocation and function. Endocrinology. 1999;140:4359–66.PubMedCrossRef

43.

Bogaert TV, Vandevyver S, Dejager L, Hauwermeiren FV, Pinheiro I, Petta I, et al. TNF inhibits glucocorticoid receptor function in mice: a strong signal towards lethal shock. J Biol Chem. 2011;286:26555–67.PubMedCrossRef

44.

Dokter WH, Esselink MT, Halie MR, Vellenga E. Interleukin-4 inhibits the lipopolysaccharide-induced expression of c-jun and c-fos messenger RNA and activator protein-1 binding activity in human monocytes. Blood. 1993;81:337–43.PubMed

45.

Wei P, Vedeckis WV. Regulation of the glucocorticoid receptor gene by the AP-1 transcription factor. Endocrine. 1997;7:303–10.PubMedCrossRef

46.

Liang Q, Guo L, Gogate S, Karim Z, Hanifi A, Leung DY, et al. IL-2 and IL-4 stimulate MEK1 expression and contribute to T cell resistance against suppression by TGF-beta and IL-10 in asthma. J Immunol. 2010;185:5704–13.PubMedCrossRef

47.

Crome SQ, Wang AY, Kang CY, Levings MK. The role of retinoic acid-related orphan receptor variant 2 and IL-17 in the development and function of human CD4+ T cells. Eur J Immunol. 2009;39:1480–93.PubMedCrossRef

48.

Paliogianni F, Ahuja SS, Balow JP, Balow JE, Boumpas DT. Novel mechanism for inhibition of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through IL-2 receptor. J Immunol. 1993;151:4081–9.PubMed

49.

White SR, Dorscheid DR. Corticosteroid-induced apoptosis of airway epithelium: a potential mechanism for chronic airway epithelial damage in asthma. Chest. 2002;122:278S–84S.PubMedCrossRef

50.

You Z, Shi X, Duraine G, Haudenschild D, Tepper C, et al. Interleukin-17 receptor-like gene is a novel anti-apoptotic gene highly expressed in androgen-independent prostate cancer. Cancer Res. 2006;66:175–83.PubMedCrossRef

51.

Zhu F, Wang Q, Guo C, Wang X, Cao X, Shi Y, et al. IL-17 induces apoptosis of vascular endothelial cells: a potential mechanism for human acute coronary syndrome. Clin Immunol. 2011;141:152–60.PubMedCrossRef

52.

Graninger WB, Steiner CW, Graninger MT, Aringer M, Smolen JS. Cytokine regulation of apoptosis and Bcl-2 expression in lymphocytes of patients with systemic lupus erythematosus. Cell Death Differ. 2000;7:966–72.PubMedCrossRef

53.

Cocco C, Canale S, Frasson C, Di Carlo E, Ognio E, Ribatti D, et al. Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells. Blood. 2010;116:3887–98.PubMedCrossRef

54.

Wang JC, Derynck MK, Nonaka DF, Khodabakhsh DB, Haqq C, Yamamoto KR. Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes. Proc Natl Acad Sci USA. 2004;101:15603–8.PubMedCrossRef

55.

Asselin-Labat ML, Biola-Vidamment A, Kerbrat S, Lombes M, Bertoglio J, Pallardy M. Foxp3 mediates antagonistic effects of glucocorticoids and interleukin-2 on glucocorticoid-induced leucine zipper expression. Mol Endocrinol. 2005;19:1752–64.PubMedCrossRef

56.

Hearing SD, Norman M, Smyth C, Foy C, Dayan CM. Wide variation in lymphocyte steroid sensitivity among healthy human volunteers. J Clin Endocrinol Metab. 1999;84:4149–54.PubMedCrossRef

57.

Tse SM, Tantisira K, Weiss ST. The pharmacogenetics andpharmacogenomics of asthma therapy. Pharmacogenomics J. 2011;11:383–92.PubMedCrossRef

58.

Franscini N, Bachli EB, Blau N, Leikauf MS, Schaffner A, Schoedon G. Gene expression profiling of inflamed human endothelial cells and influence of activated protein C. Circulation. 2004;110:2903–9.PubMedCrossRef

59.

Masuno K, Haldar SM, Jeyaraj D, Mailloux CM, Huang X, Panettieri Jr RA, Jain MK, Gerber AN. Expression profiling identifies Klf15 as a glucocorticoid target that regulates airway hyperresponsiveness. Am J Respir Cell Mol Biol. 2011;45:642–9.PubMedCrossRef

60.

Hedman E, Widen C, Asadi A, Dinnetz I, Schroder WP, Gustafsson JA, Wikstrom AC. Proteomic identification of glucocorticoid receptor interacting proteins. Proteomics. 2006;6:3114–26.PubMedCrossRef

Titel: Glucocorticoid Receptor-Beta Up-Regulation and Steroid Resistance Induction by IL-17 and IL-23 Cytokine Stimulation in Peripheral Mononuclear Cells
verfasst von: Alejandro Vazquez-Tello
Rabih Halwani
Qutayba Hamid
Saleh Al-Muhsen
Publikationsdatum: 01.02.2013
Verlag: Springer US
Erschienen in: Journal of Clinical Immunology / Ausgabe 2/2013
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI: https://doi.org/10.1007/s10875-012-9828-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2013

Expression of IL-27, Th1 and Th17 in Patients with Aplastic Anemia

Broadened T-cell Repertoire Diversity in ivIg-treated SLE Patients is Also Related to the Individual Status of Regulatory T-cells

Anti-Annexin V Antibodies in Primary Fibromyalgia Syndrome: Relation to Associated Sjögren’s Syndrome

Comment on Neuromyelitis Optica: Potential Roles for Intravenous Immunoglobulin

Serotype-Specific Anti-Pneumococcal IgG and Immune Competence: Critical Differences in Interpretation Criteria When Different Methods are Used